Showing results (11-20 of 153) with videos related to
Sort By:
Pageof 16
The Oncologist|July 19, 2011
FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulationsAmir T Fathi, Bruce A ChabnerCroatian Medical Journal|May 30, 2002
Mechanisms of action and potential therapeutic uses of thalidomideHamza Mujagić, Bruce A Chabner, Zlata MujagićThe Oncologist|February 26, 2011
Reflections on the knife edgeJohn Patrick Michael Murphy, Bruce A ChabnerCancer Discovery|February 17, 2019
Targeting Alterations in the RAF-MEK PathwayRona Yaeger, Ryan B CorcoranCancer Discovery|October 4, 2018
Blood-Based Prediction of Tumor Relapse: The cfDNA ForecastGiulia Siravegna, Ryan B CorcoranJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improving Prospects for Targeting RASHarshabad Singh, Dan L Longo, Bruce A ChabnerProceedings of the National Academy of Sciences of the United States of America|May 19, 2006
Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cellsRyan B Corcoran, Matthew P ScottNature Reviews. Clinical Oncology|October 3, 2018
Therapeutic strategies to target RAS-mutant cancersMeagan B Ryan, Ryan B CorcoranGenome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B CorcoranMolecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B CorcoranPageof 16